Skip to content



Sort by
Page 1 of 59
  1. Content type: Original investigation

    Patients with type 1 diabetes are more at risk of coronary artery disease than the general population. Although evidence points to a genetic risk there have been no study investigating genetic risk factors of ...

    Authors: Romain Charmet, Seamus Duffy, Sareh Keshavarzi, Beata Gyorgy, Michel Marre, Peter Rossing, Amy Jayne McKnight, Alexander P. Maxwell, Tarun veer Singh Ahluwalia, Andrew D. Paterson, David-Alexandre Trégouët and Samy Hadjadj

    Citation: Cardiovascular Diabetology 2018 17:61

    Published on:

  2. Content type: Review

    Multiple population based analyses have demonstrated a high incidence of cardiovascular disease (CVD) and cardiovascular (CV) mortality in subjects with T2DM that reduces life expectancy by as much as 15 years...

    Authors: Annayya R. Aroor, Camila Manrique-Acevedo and Vincent G. DeMarco

    Citation: Cardiovascular Diabetology 2018 17:59

    Published on:

  3. Content type: Original investigation

    Type 2 diabetes mellitus (T2D) is associated with the development of left ventricular systolic dysfunction (LVSD) and heart failure with reduced ejection fraction (HFrEF). T2D patients with LVSD are at higher ...

    Authors: Selma Bouthoorn, Aisha Gohar, Gideon Valstar, Hester M. den Ruijter, J. B. Reitsma, Arno W. Hoes and Frans H. Rutten

    Citation: Cardiovascular Diabetology 2018 17:58

    Published on:

  4. Content type: Review

    Cardiovascular disease (CVD) is the leading cause of mortality in people with type 2 diabetes mellitus (T2DM), yet a significant proportion of the disease burden cannot be accounted for by conventional cardiov...

    Authors: W. David Strain and P. M. Paldánius

    Citation: Cardiovascular Diabetology 2018 17:57

    Published on:

  5. Content type: Original investigation

    It has been suggested that liraglutide could have an impact on glucose and lipid metabolism disorder and adhesion molecule activation, which may play important roles in the vascular damage of diabetes. In this...

    Authors: Xiao-min Chen, Wen-qiang Zhang, Yuan Tian, Li-fen Wang, Chan-chan Chen and Chuan-mei Qiu

    Citation: Cardiovascular Diabetology 2018 17:53

    Published on:

  6. Content type: Original investigation

    To evaluate real-world patient characteristics, medication use, and health care utilization patterns in patients with type 2 diabetes with established cardiovascular disease (CVD).

    Authors: Kevin M. Pantalone, Anita D. Misra-Hebert, Todd M. Hobbs, Xinge Ji, Sheldon X. Kong, Alex Milinovich, Wayne Weng, Janine Bauman, Rahul Ganguly, Bartolome Burguera, Michael W. Kattan and Robert S. Zimmerman

    Citation: Cardiovascular Diabetology 2018 17:54

    Published on:

  7. Content type: Original investigation

    Sarcopenic obesity, defined as reduced skeletal muscle mass and power with increased adiposity, was reported to be associated with cardiovascular disease risks in previous cross-sectional studies. Whole body d...

    Authors: Tatsuya Fukuda, Ryotaro Bouchi, Takato Takeuchi, Kazutaka Tsujimoto, Isao Minami, Takanobu Yoshimoto and Yoshihiro Ogawa

    Citation: Cardiovascular Diabetology 2018 17:55

    Published on:

  8. Content type: Original investigation

    Cardiovascular protection following empagliflozin therapy is not entirely attributable to the glucose lowering effect. Increased hematocrit might influence the shear stress that is the main force acting on the...

    Authors: Concetta Irace, Francesco Casciaro, Faustina Barbara Scavelli, Rosa Oliverio, Antonio Cutruzzolà, Claudio Cortese and Agostino Gnasso

    Citation: Cardiovascular Diabetology 2018 17:52

    Published on:

  9. Content type: Original investigation

    The effect of change in blood glucose levels on the risk of cardiovascular disease among individuals without diabetes is currently unclear. We aimed to examine the association of change in fasting serum glucos...

    Authors: Gyeongsil Lee, Sung Min Kim, Seulggie Choi, Kyuwoong Kim, Su-Min Jeong, Joung Sik Son, Jae-Moon Yun and Sang Min Park

    Citation: Cardiovascular Diabetology 2018 17:51

    Published on:

  10. Content type: Original investigation

    The urinary proteomic classifier CKD273 has shown promise for prediction of progressive diabetic nephropathy (DN). Whether it is also a determinant of mortality and cardiovascular disease in patients with micr...

    Authors: Gemma E. Currie, Bernt Johan von Scholten, Sheon Mary, Jose-Luis Flores Guerrero, Morten Lindhardt, Henrik Reinhard, Peter K. Jacobsen, William Mullen, Hans-Henrik Parving, Harald Mischak, Peter Rossing and Christian Delles

    Citation: Cardiovascular Diabetology 2018 17:50

    Published on:

  11. Content type: Correction

    The author found errors in Table 1 after publication of the original article [1].

    Authors: Núria Alonso, Alicia Traveset, Esther Rubinat, Emilio Ortega, Nuria Alcubierre, Jordi Sanahuja, Marta Hernández, Angels Betriu, Carmen Jurjo, Elvira Fernández and Didac Mauricio

    Citation: Cardiovascular Diabetology 2018 17:49

    Published on:

    The original article was published in Cardiovascular Diabetology 2015 14:33

  12. Content type: Original investigation

    Proprotein convertase subtilisin/kexin type 9 (PCSK9), a major regulator of cholesterol homeostasis, is associated with glucose metabolism. Liraglutide, a glucagon-like peptide-1 receptor agonist, can increase...

    Authors: Sheng-Hua Yang, Rui-Xia Xu, Chuan-Jue Cui, Yin Wang, Ying Du, Zhi-Guo Chen, Yu-Hong Yao, Chun-Yan Ma, Cheng-Gang Zhu, Yuan-Lin Guo, Na-Qiong Wu, Jing Sun, Bu-Xing Chen and Jian-Jun Li

    Citation: Cardiovascular Diabetology 2018 17:48

    Published on:

  13. Content type: Original investigation

    Diabetic complications may be associated with impaired time-dependent glycemic control. Therefore, long-term glycemic variability, assessed by variations in haemoglobin A1c (HbA1c), may be a potential risk fac...

    Authors: Jian-bin Su, Li-hua Zhao, Xiu-lin Zhang, Hong-li Cai, Hai-yan Huang, Feng Xu, Tong Chen and Xue-qin Wang

    Citation: Cardiovascular Diabetology 2018 17:47

    Published on:

  14. Content type: Original investigation

    In the last decade, several studies have reported an unexpected and seemingly paradoxical inverse correlation between BMI and incidence of cardiovascular diseases. This so called “obesity paradox effect” has b...

    Authors: Valentina Rovella, Lucia Anemona, Marina Cardellini, Manuel Scimeca, Andrea Saggini, Giuseppe Santeusanio, Elena Bonanno, Manuela Montanaro, Iacopo Maria Legramante, Arnaldo Ippoliti, Nicola Di Daniele, Massimo Federici and Alessandro Mauriello

    Citation: Cardiovascular Diabetology 2018 17:46

    Published on:

  15. Content type: Original investigation

    The reasons for reduced exercise capacity in diabetes mellitus (DM) remains incompletely understood, although diastolic dysfunction and diabetic cardiomyopathy are often favored explanations. However, there is...

    Authors: Timothy J. Roberts, Andrew T. Burns, Richard J. MacIsaac, Andrew I. MacIsaac, David L. Prior and André La Gerche

    Citation: Cardiovascular Diabetology 2018 17:44

    Published on:

  16. Content type: Original investigation

    Vascular calcifications are associated with a three- to fourfold increased risk of cardiovascular disease (CVD) and are highly prevalent in type 2 diabetes patients. Emerging evidence indicates that vascular c...

    Authors: Sabine R. Zwakenberg, Yvonne T. van der Schouw, Casper G. Schalkwijk, Annemieke M. W. Spijkerman and Joline W. J. Beulens

    Citation: Cardiovascular Diabetology 2018 17:45

    Published on:

  17. Content type: Correction

    The authors found errors in Table 1 after publication of the original article [1].

    Authors: Iren D. Hjellestad, Marianne C. Astor, Roy M. Nilsen, Eirik Søfteland and Torbjørn Jonung

    Citation: Cardiovascular Diabetology 2018 17:42

    Published on:

    The original article was published in Cardiovascular Diabetology 2013 12:79

  18. Content type: Original investigation

    The triglyceride glucose (TyG) index has been suggested as a simple surrogate marker of insulin resistance. However, there are limited data regarding the association between the TyG index and arterial stiffnes...

    Authors: Sang Bae Lee, Chul Woo Ahn, Byoung Kwon Lee, Shinae Kang, Ji Sun Nam, Ji Hong You, Min Jin Kim, Min Kyung Kim and Jong Suk Park

    Citation: Cardiovascular Diabetology 2018 17:41

    Published on:

  19. Content type: Original investigation

    Determination of the impact of visceral obesity and epicardial adipose tissue thickness on stimulating growth factor levels during hospitalization for myocardial infarction is of potential importance for predi...

    Authors: Olga Gruzdeva, Evgenya Uchasova, Yulia Dyleva, Daria Borodkina, Olga Akbasheva, Ekaterina Belik, Viktoria Karetnikova, Natalia Brel, Alexander Kokov, Vasiliy Kashtalap and Olga Barbarash

    Citation: Cardiovascular Diabetology 2018 17:40

    Published on:

  20. Content type: Original investigation

    Cardiovascular (CV) outcome trials in type 2 diabetes (T2D) have underrepresented patients with chronic kidney disease (CKD), leading to uncertainty regarding their kidney efficacy and safety. The CARMELINA® tria...

    Authors: Julio Rosenstock, Vlado Perkovic, John H. Alexander, Mark E. Cooper, Nikolaus Marx, Michael J. Pencina, Robert D. Toto, Christoph Wanner, Bernard Zinman, David Baanstra, Egon Pfarr, Michaela Mattheus, Uli C. Broedl, Hans-Juergen Woerle, Jyothis T. George, Maximilian von Eynatten…

    Citation: Cardiovascular Diabetology 2018 17:39

    Published on:

  21. Content type: Correction

    Following publication of the original article [1] the authors reported that the first affiliation (“Medical Center of the Graduate School, Nanchang University, China”) had been added in error, and that the cor...

    Authors: Honghong Zou, Baoqin Zhou and Gaosi Xu

    Citation: Cardiovascular Diabetology 2018 17:38

    Published on:

    The original article was published in Cardiovascular Diabetology 2017 16:65

  22. Content type: Original investigation

    It is presently unclear whether glycemic variability (GV) is associated with baroreflex sensitivity (BRS), which is an early indicator of cardiovascular autonomic neuropathy. The present study is the first to ...

    Authors: Daisuke Matsutani, Masaya Sakamoto, Hiroyuki Iuchi, Souichirou Minato, Hirofumi Suzuki, Yosuke Kayama, Norihiko Takeda, Ryuzo Horiuchi and Kazunori Utsunomiya

    Citation: Cardiovascular Diabetology 2018 17:36

    Published on:

  23. Content type: Original investigation

    We aimed to investigate in patients with type 2 diabetes whether aortic stiffness is: (i) associated with glycaemic control, (ii) associated with adverse outcomes and (iii) can be reversed on treatment with RA...

    Authors: Peter P. Swoboda, Bara Erhayiem, Rachel Kan, Adam K. McDiarmid, Pankaj Garg, Tarique A. Musa, Laura E. Dobson, Klaus K. Witte, Mark T. Kearney, Julian H. Barth, Ramzi Ajjan, John P. Greenwood and Sven Plein

    Citation: Cardiovascular Diabetology 2018 17:35

    Published on:

Page 1 of 59
journal logo

2016 Journal Metrics